CDK4 and posterior cortical atrophy: Moreover, CDK6 can promote PCa progression stimulating AR activity [28], and CDK4/6 inhibitors (combined olaparib and palbociblib treatment or abemaciclib) have been shown to induce apoptosis in PCa cell lines [29].